Affimed Nv Stock Today
| AFMD Stock | USD 5.00 0.15 2.91% |
Performance0 of 100
| Odds Of DistressOver 85
|
Affimed NV is trading at 5.00 as of the 23rd of April 2024, a -2.91% down since the beginning of the trading day. The stock's lowest day price was 4.72. Affimed NV has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Affimed NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of May 2022 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 12th of September 2014 | Category Healthcare | Classification Health Care |
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 15.23 M outstanding shares of which 196.43 K shares are presently shorted by private and institutional investors with about 1.65 trading days to cover. More on Affimed NV
Follow Valuation Options Odds of Bankruptcy
Financial Report 28th of May 2024
Affimed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Affimed NV's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Affimed NV or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Adi Hoess | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Affimed NV report their recommendations after researching Affimed NV's financial statements, talking to executives and customers, or listening in on Affimed NV's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Affimed NV. The Affimed consensus assessment is calculated by taking the average forecast from all of the analysts covering Affimed NV. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Affimed NV's liquidity, profitability, solvency, and operating efficiency, Affimed NV is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Affimed NV is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Affimed NV's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Affimed NV's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Affimed NV's financial leverage. It provides some insight into what part of Affimed NV's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Affimed NV (AFMD) is traded on NASDAQ Exchange in USA. It is located in Gottlieb-Daimler-Straße 2, Mannheim, Germany, 68165 and employs 76 people. Affimed NV is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 76.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Affimed NV's market, we take the total number of its shares issued and multiply it by Affimed NV's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Affimed NV conducts business under Biotechnology sector and is part of Health Care industry. The entity has 15.23 M outstanding shares of which 196.43 K shares are presently shorted by private and institutional investors with about 1.65 trading days to cover.
Affimed NV currently holds about 237.23 M in cash with (110.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59.
Check Affimed NV Probability Of Bankruptcy
Ownership AllocationAffimed NV retains a total of 15.23 Million outstanding shares. 30% of Affimed NV outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Affimed Ownership Details
Affimed Stock Price Odds Analysis
What are Affimed NV's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Affimed NV jumping above the current price in 90 days from now is about 88.27%. The Affimed NV probability density function shows the probability of Affimed NV stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Affimed NV has a beta of 0.958. This suggests Affimed NV market returns are highly-sensitive to returns on the market. As the market goes up or down, Affimed NV is expected to follow. Additionally, affimed NV has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Affimed NV to move above the current price in 90 days from now is about 88.27 (This Affimed NV probability density function shows the probability of Affimed Stock to fall within a particular range of prices over 90 days) .
Affimed Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Affimed NV that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Affimed NV's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Affimed NV's value.| Instituion | Recorded On | Shares | |
| Two Sigma Investments Llc | 2023-12-31 | 631.6 K | |
| Marshall Wace Asset Management Ltd | 2023-12-31 | 607.3 K | |
| Bnp Paribas Arbitrage, Sa | 2023-12-31 | 572 K | |
| Vestal Point Capital Lp | 2023-12-31 | 546.1 K | |
| State Street Corporation | 2023-12-31 | 529.4 K | |
| Intellectus Partners, Llc | 2023-12-31 | 410.4 K | |
| Alyeska Investment Group, L.p. | 2023-09-30 | 350 K | |
| Ubs O'connor Llc | 2023-12-31 | 254.9 K | |
| Abrdn Plc | 2023-12-31 | 208.6 K | |
| 683 Capital Management Llc | 2023-12-31 | 7 M | |
| Nea Management Company, Llc | 2023-12-31 | 4.4 M |
Affimed NV Historical Income Statement
Affimed NV Income Statement is one of the three primary financial statements used for reporting Affimed's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Affimed NV revenue and expense. Affimed NV Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Affimed NV's Research Development is projected to increase significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 5.2 M, whereas Selling General Administrative is forecasted to decline to about 13.8 M. View More FundamentalsAffimed Stock Against Markets
Picking the right benchmark for Affimed NV stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Affimed NV stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Affimed NV is critical whether you are bullish or bearish towards Affimed NV at a given time. Please also check how Affimed NV's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Affimed NV without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Affimed NV Corporate Management
Elected by the shareholders, the Affimed NV's board of directors comprises two types of representatives: Affimed NV inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Affimed. The board's role is to monitor Affimed NV's management team and ensure that shareholders' interests are well served. Affimed NV's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Affimed NV's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angus Smith | CFO Board | Profile | |
| Michael Wolf | Head Administration | Profile | |
| Ferdinand Verdonck | Member of the Supervisory Board | Profile | |
| Ulrich Grau | Member of the Supervisory Board | Profile | |
| Pr Little | Founder Consultant | Profile |
How to buy Affimed Stock?
Before investing in Affimed NV, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Affimed NV. To buy Affimed NV stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Affimed NV. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Affimed NV stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Affimed NV stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Affimed NV stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Affimed NV, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Affimed Stock please use our How to Invest in Affimed NV guide.
Already Invested in Affimed NV?
The danger of trading Affimed NV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Affimed NV is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Affimed NV. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Affimed NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Affimed NV is a strong investment it is important to analyze Affimed NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Affimed NV's future performance. For an informed investment choice regarding Affimed Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Affimed Stock analysis
When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Affimed NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.56) | Revenue Per Share 0.931 | Quarterly Revenue Growth (0.58) | Return On Assets (0.43) | Return On Equity (1.01) |
The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.